Comparison of standard vs. palliative management for bladder cancer in patients older than 85 years: multicenter study of 317 de novo tumors.

CONCLUSIONS: Chronological age should not be a contraindication for applying standard therapies in NMIBC. In MIBC the survival is low regardless of the type of management. The lack of correlation between OS and ASA or Charlson-score raises the necessity of a geriatric assessment for selecting the best treatment strategy.
PMID: 31586544 [PubMed - as supplied by publisher]

Source: Urologic Oncology - October 1, 2019 Category: Urology & Nephrology Authors: Carrion A, Huguet J, Ribal MJ, Domínguez A, Bonet X, Servián P, Mayordomo O, Ajami T, Piccola N, Freixa R, Díaz F, Lozano F, Raventós C, Morote J Tags: Urol Oncol Source Type: research